Abstract
Multiple sclerosis (MS) is a chronic condition affecting the central nervous system (CNS), where the interplay of genetic and environmental factors influences its pathophysiology, triggering immune responses and instigating inflammation. Contemporary research has been notably dedicated to investigating the contributions of gut microbiota and their metabolites in modulating inflammatory reactions within the CNS. Recent recognition of the gut microbiome and dietary patterns as environmental elements impacting MS development emphasizes the potential influence of small, ubiquitous molecules from microbiota, such as short-chain fatty acids (SCFAs). These molecules may serve as vital molecular signals or metabolic substances regulating host cellular metabolism in the intricate interplay between microbiota and the host. A current emphasis lies on optimizing the health-promoting attributes of colonic bacteria to mitigate urinary tract issues through dietary management. This review aims to spotlight recent investigations on the impact of SCFAs on immune cells pivotal in MS, the involvement of gut microbiota and SCFAs in MS development, and the considerable influence of probiotics on gastrointestinal disruptions in MS. Comprehending the gut-CNS connection holds promise for the development of innovative therapeutic approaches, particularly probiotic-based supplements, for managing MS.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data Availability
No datasets were generated or analysed during the current study.
References
Acar, G., İdiman, F., İdiman, E., Kırkalı, G., Çakmakçı, H., & Özakbaş, S. (2003). Nitric oxide as an activity marker in multiple sclerosis. Journal of Neurology, 250(5), 588–592. https://doi.org/10.1007/s00415-003-1041-0
Akhtar, M., Chen, Y., Ma, Z., Zhang, X., Shi, D., Khan, J. A., et al. (2022). Gut microbiota-derived short chain fatty acids are potential mediators in gut inflammation. Anim Nutr, 8, 350–360. https://doi.org/10.1016/j.aninu.2021.11.005
Alexander, C., Swanson, K. S., Fahey, G. C., Jr., & Garleb, K. A. (2019). Perspective: Physiologic importance of short-chain fatty acids from nondigestible carbohydrate fermentation. Advances in Nutrition, 10(4), 576–589.
Alva-Murillo, N., Ochoa-Zarzosa, A., & López-Meza, J. E. (2012). Short chain fatty acids (propionic and hexanoic) decrease Staphylococcus aureus internalization into bovine mammary epithelial cells and modulate antimicrobial peptide expression. Veterinary Microbiology, 155(2), 324–331. https://doi.org/10.1016/j.vetmic.2011.08.025
Amato, M., Hakiki, B., Goretti, B., Rossi, F., Stromillo, M. L., Giorgio, A., et al. (2012). Association of MRI metrics and cognitive impairment in radiologically isolated syndromes. Neurology, 78(5), 309–314.
Amon, P., & Sanderson, I. (2017). What is the microbiome? Archives of Disease in Childhood-Education and Practice, 102(5), 257–260.
Antunes, K. H., Fachi, J. L., de Paula, R., da Silva, E. F., Pral, L. P., dos Santos, A. Á., et al. (2019). Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response. Nature Communications, 10(1), 3273. https://doi.org/10.1038/s41467-019-11152-6
Aoyama, M., Kotani, J., & Usami, M. (2010a). Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41/GPR-43 pathways. Nutrition, 26(6), 653–661. https://doi.org/10.1016/j.nut.2009.07.006
Aoyama, M., Kotani, J., & Usami, M. (2010b). Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41/GPR-43 pathways. Nutrition, 26(6), 653–661.
Arora, T., Sharma, R., & Frost, G. (2011). Propionate. Anti-obesity and satiety enhancing factor? Appetite, 56(2), 511–515.
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., Van Der Veeken, J., Deroos, P., et al. (2013a). Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature, 504(7480), 451–455.
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., et al. (2013b). Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature, 504(7480), 451–455. https://doi.org/10.1038/nature12726
Artis, D., & Spits, H. (2015). The biology of innate lymphoid cells. Nature, 517(7534), 293–301. https://doi.org/10.1038/nature14189
Baars, A., Oosting, A., Lohuis, M., Koehorst, M., El Aidy, S., Hugenholtz, F., et al. (2018). Sex differences in lipid metabolism are affected by presence of the gut microbiota. Scientific Reports, 8(1), 13426.
Backhed, F., Manchester, J., Semenkovich, C., & Gordon, J. I. (2007). Mechanisms underlying the resistance to diet induced obesity in germ-free mice. Proceedings of the National Academy of Sciences, 104, 979–984.
Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018). Multiple sclerosis: Mechanisms and immunotherapy. Neuron, 97(4), 742–768.
Bailey, S. L., Schreiner, B., McMahon, E. J., & Miller, S. D. (2007). CNS myeloid DCs presenting endogenous myelin peptides “preferentially” polarize CD4+ T(H)-17 cells in relapsing EAE. Nature Immunology, 8(2), 172–180. https://doi.org/10.1038/ni1430
Balashov, K. E., Comabella, M., Ohashi, T., Khoury, S. J., & Weiner, H. L. (2000). Defective regulation of IFNγ and IL-12 by endogenous IL-10 in progressive MS. Neurology, 55(2), 192–198.
Beecham, A. H., Patsopoulos, N. A., Xifara, D. K., Davis, M. F., Kemppinen, A., Cotsapas, C., et al. (2013). Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nature Genetics, 45(11), 1353–1360. https://doi.org/10.1038/ng.2770
Benedek, G., Zhang, J., Nguyen, H., Kent, G., Seifert, H. A., Davin, S., et al. (2017). Estrogen protection against EAE modulates the microbiota and mucosal-associated regulatory cells. Journal of Neuroimmunology, 310, 51–59.
Berndt, B. E., Zhang, M., Owyang, S. Y., Cole, T. S., Wang, T. W., Luther, J., et al. (2012). Butyrate increases IL-23 production by stimulated dendritic cells. American Journal of Physiology. Gastrointestinal and Liver Physiology, 303(12), G1384-1392. https://doi.org/10.1152/ajpgi.00540.2011
Bernink, J. H., Peters, C. P., Munneke, M., Te Velde, A. A., Meijer, S. L., Weijer, K., et al. (2013). Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nature Immunology, 14(3), 221–229.
Bert, S., Nadkarni, S., & Perretti, M. (2023). Neutrophil-T cell crosstalk and the control of the host inflammatory response. Immunological Reviews, 314(1), 36–49.
Bolnick, D. I., Snowberg, L. K., Hirsch, P. E., Lauber, C. L., Org, E., Parks, B., et al. (2014). Individual diet has sex-dependent effects on vertebrate gut microbiota. Nature Communications, 5(1), 4500.
Bourassa, M. W., Alim, I., Bultman, S. J., & Ratan, R. R. (2016). Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health? Neuroscience Letters, 625, 56–63.
Brown, E. M., Allsopp, P. J., Magee, P. J., Gill, C. I., Nitecki, S., Strain, C. R., et al. (2014). Seaweed and human health. Nutrition Reviews, 72(3), 205–216.
Browne, P., Chandraratna, D., Angood, C., Tremlett, H., Baker, C., Taylor, B. V., et al. (2014). Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity. Neurology, 83(11), 1022–1024. https://doi.org/10.1212/wnl.0000000000000768
Burokas, A., Arboleya, S., Moloney, R. D., Peterson, V. L., Murphy, K., Clarke, G., et al. (2017). Targeting the microbiota-gut-brain axis: Prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice. Biological Psychiatry, 82(7), 472–487.
Calvo-Barreiro, L., Eixarch, H., Cornejo, T., Costa, C., Castillo, M., Mestre, L., et al. (2021). Selected clostridia strains from the human microbiota and their metabolite, butyrate improve experimental autoimmune encephalomyelitis. Neurotherapeutics, 18(2), 920–937. https://doi.org/10.1007/s13311-021-01016-7
Camara-Lemarroy, C. R., Silva, C., Greenfield, J., Liu, W.-Q., Metz, L. M., & Yong, V. W. (2020). Biomarkers of intestinal barrier function in multiple sclerosis are associated with disease activity. Multiple Sclerosis Journal, 26(11), 1340–1350.
Cantarel, B. L., Waubant, E., Chehoud, C., Kuczynski, J., DeSantis, T. Z., Warrington, J., et al. (2015). Gut microbiota in multiple sclerosis: Possible influence of immunomodulators. Journal of Investigative Medicine, 63(5), 729–734.
Cantoni, C., Lin, Q., Dorsett, Y., Ghezzi, L., Liu, Z., Pan, Y., et al. (2022). Alterations of host-gut microbiome interactions in multiple sclerosis. eBioMedicine. https://doi.org/10.1016/j.ebiom.2021.103798
Cassatella, M. A. (1995). The production of cytokines by polymorphonuclear neutrophils. Immunology Today, 16(1), 21–26. https://doi.org/10.1016/0167-5699(95)80066-2
Casserly, C. S., Nantes, J. C., Whittaker Hawkins, R. F., & Vallières, L. (2017). Neutrophil perversion in demyelinating autoimmune diseases: Mechanisms to medicine. Autoimmunity Reviews, 16(3), 294–307. https://doi.org/10.1016/j.autrev.2017.01.013
Castillo-Alvarez, F., Perez-Matute, P., Oteo, J., & Marzo-Sola, M. (2021). The influence of interferon β-1b on gut microbiota composition in patients with multiple sclerosis. Neurología (english Edition), 36(7), 495–503.
Chang, P. V., Hao, L., Offermanns, S., & Medzhitov, R. (2014). The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proceedings of the National Academy of Sciences, 111(6), 2247–2252.
Chastain, E. M., & Miller, S. D. (2012). Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease. Immunological Reviews, 245(1), 227–238.
Chen, J., Chia, N., Kalari, K. R., Yao, J. Z., Novotna, M., Paz Soldan, M. M., et al. (2016a). Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Scientific Reports, 6(1), 28484.
Chen, J., Chia, N., Kalari, K. R., Yao, J. Z., Novotna, M., Paz Soldan, M. M., et al. (2016b). Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Science and Reports, 6, 28484. https://doi.org/10.1038/srep28484
Chen, L., Sun, M., Wu, W., Yang, W., Huang, X., Xiao, Y., et al. (2019a). Microbiota metabolite butyrate differentially regulates Th1 and Th17 cells’ differentiation and function in induction of colitis. Inflammatory Bowel Diseases, 25(9), 1450–1461. https://doi.org/10.1093/ibd/izz046
Chen, M. L., & Sundrud, M. S. (2016). Cytokine networks and T-cell subsets in inflammatory bowel diseases. Inflammatory Bowel Diseases, 22(5), 1157–1167.
Chen, T., Noto, D., Hoshino, Y., Mizuno, M., & Miyake, S. (2019b). Butyrate suppresses demyelination and enhances remyelination. Journal of Neuroinflammation, 16(1), 1–13.
Cheng, Y., Liu, J., & Ling, Z. (2022). Short-chain fatty acids-producing probiotics: A novel source of psychobiotics. Critical Reviews in Food Science and Nutrition, 62(28), 7929–7959.
Choi, I.-Y., Lee, S., Denney, D. R., & Lynch, S. G. (2011). Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T. Multiple Sclerosis Journal, 17(3), 289–296.
Chun, E., Lavoie, S., Fonseca-Pereira, D., Bae, S., Michaud, M., Hoveyda, H. R., et al. (2019). Metabolite-sensing receptor Ffar2 regulates colonic group 3 innate lymphoid cells and gut immunity. Immunity, 51(5), 871-884.e876. https://doi.org/10.1016/j.immuni.2019.09.014
Claflin, S. B., Broadley, S., & Taylor, B. V. (2018). The effect of disease modifying therapies on disability progression in multiple sclerosis: a systematic overview of meta-analyses. Frontiers in Neurology, 9, 1150. https://doi.org/10.3389/fneur.2018.01150
Clarkson, B. D., Walker, A., Harris, M. G., Rayasam, A., Hsu, M., Sandor, M., et al. (2017). CCR7 deficient inflammatory Dendritic Cells are retained in the Central Nervous System. Science and Reports, 7, 42856. https://doi.org/10.1038/srep42856
Clarkson, B. D., Walker, A., Harris, M., Rayasam, A., Sandor, M., & Fabry, Z. (2014). Mapping the accumulation of co-infiltrating CNS dendritic cells and encephalitogenic T cells during EAE. Journal of Neuroimmunology, 277(1–2), 39–49. https://doi.org/10.1016/j.jneuroim.2014.09.016
Colonna, M. (2018). Innate lymphoid cells: Diversity, plasticity, and unique functions in immunity. Immunity, 48(6), 1104–1117.
Colpitts, S. L., & Kasper, L. H. (2017). Influence of the gut microbiome on autoimmunity in the central nervous system. The Journal of Immunology, 198(2), 596–604. https://doi.org/10.4049/jimmunol.1601438
Confavreux, C., Vukusic, S., & Adeleine, P. (2003). Early clinical predictors and progression of irreversible disability in multiple sclerosis: An amnesic process. Brain, 126(Pt 4), 770–782. https://doi.org/10.1093/brain/awg081
Consolandi, C., Turroni, S., Emmi, G., Severgnini, M., Fiori, J., Peano, C., et al. (2015). Behçet’s syndrome patients exhibit specific microbiome signature. Autoimmunity Reviews, 14(4), 269–276.
Constantinescu, C. S., Farooqi, N., O’Brien, K., & Gran, B. (2011). Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). British Journal of Pharmacology, 164(4), 1079–1106. https://doi.org/10.1111/j.1476-5381.2011.01302.x
Constantinides, M. G. (2017). Interactions between the microbiota and innate and innate-like lymphocytes. Journal of Leukocyte Biology, 103(3), 409–419. https://doi.org/10.1002/jlb.3ri0917-378r
Corrêa, R. O., Vieira, A., Sernaglia, E., Lancellotti, M., Vieira, A., Avila-Campos, M. J., et al. (2017). Bacterial short-chain fatty acid metabolites modulate the inflammatory response against infectious bacteria. Cellular Microbiology, 19(7), e12720.
Cosgrove, K. P., Mazure, C. M., & Staley, J. K. (2007). Evolving knowledge of sex differences in brain structure, function, and chemistry. Biological Psychiatry, 62(8), 847–855.
Cosorich, I., Dalla-Costa, G., Sorini, C., Ferrarese, R., Messina, M. J., Dolpady, J., et al. (2017). High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis. Science Advances, 3(7), e1700492.
Covarrubias, A. J., Aksoylar, H. I., Yu, J., Snyder, N. W., Worth, A. J., Iyer, S. S., et al. (2016). Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation. eLife. https://doi.org/10.7554/eLife.11612
Cox, M. A., Jackson, J., Stanton, M., Rojas-Triana, A., Bober, L., Laverty, M., et al. (2009). Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E2 and cytokines. World Journal of Gastroenterology: WJG, 15(44), 5549.
Cree, B. A. C., Arnold, D. L., Chataway, J., Chitnis, T., Fox, R. J., Ramajo, A. P., et al. (2021). Secondary progressive multiple sclerosis. New Insights, 97(8), 378–388. https://doi.org/10.1212/wnl.0000000000012323
Cristofori, F., Dargenio, V. N., Dargenio, C., Miniello, V. L., Barone, M., & Francavilla, R. (2021). Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: A door to the body. Frontiers in Immunology, 12, 578386.
Croxford, A. L., Lanzinger, M., Hartmann, F. J., Schreiner, B., Mair, F., Pelczar, P., et al. (2015). The cytokine GM-CSF drives the inflammatory signature of CCR2+ monocytes and licenses autoimmunity. Immunity, 43(3), 502–514.
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., et al. (2003). Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature, 421(6924), 744–748. https://doi.org/10.1038/nature01355
d’Hennezel, E., Abubucker, S., Murphy, L. O., & Cullen, T. W. (2017). Total lipopolysaccharide from the human gut microbiome silences toll-like receptor signaling. Msystems, 2(6), e00046-e117.
Dapa, T., Wong, D. P., Vasquez, K. S., Xavier, K. B., Huang, K. C., & Good, B. H. (2023). Within-host evolution of the gut microbiome. Current Opinion in Microbiology, 71, 102258.
Davenport, E. R., Sanders, J. G., Song, S. J., Amato, K. R., Clark, A. G., & Knight, R. (2017). The human microbiome in evolution. BMC Biology, 15(1), 1–12.
Dewulf, E. M., Cani, P. D., Neyrinck, A. M., Possemiers, S., Van Holle, A., Muccioli, G. G., et al. (2011). Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. The Journal of Nutritional Biochemistry, 22(8), 712–722.
Dobson, R., & Giovannoni, G. (2019). Multiple sclerosis—a review. European Journal of Neurology, 26(1), 27–40. https://doi.org/10.1111/ene.13819
Druet, P., Sheela, R., & Pelletier, L. (1995). Th1 and Th2 cells in autoimmunity. Clinical and Experimental Immunology, 101(Suppl 1), 9.
Du, H.-X., Yue, S.-Y., Niu, D., Liu, C., Zhang, L.-G., Chen, J., et al. (2022). Gut microflora modulates Th17/Treg cell differentiation in experimental autoimmune prostatitis via the short-chain fatty acid propionate. Frontiers in Immunology, 13, 915218.
Duan, H., Wang, L., Huangfu, M., & Li, H. (2023). The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials. Biomedicine & Pharmacotherapy, 165, 115276. https://doi.org/10.1016/j.biopha.2023.115276
Duffield, J. S. (2003). The inflammatory macrophage: A story of Jekyll and Hyde. Clinical Science (london, England), 104(1), 27–38.
Duscha, A., Gisevius, B., Hirschberg, S., Yissachar, N., Stangl, G. I., Dawin, E., et al. (2020a). Propionic acid shapes the multiple sclerosis disease course by an immunomodulatory mechanism. Cell, 180(6), 1067-1080.e1016. https://doi.org/10.1016/j.cell.2020.02.035
Duscha, A., Gisevius, B., Hirschberg, S., Yissachar, N., Stangl, G. I., Eilers, E., et al. (2020b). Propionic acid shapes the multiple sclerosis disease course by an immunomodulatory mechanism. Cell. https://doi.org/10.1016/j.cell.2020.02.035
Duscha, A., Hegelmaier, T., Dürholz, K., Desel, C., Gold, R., Zaiss, M. M., et al. (2022). Propionic acid beneficially modifies osteoporosis biomarkers in patients with multiple sclerosis. Therapeutic Advances in Neurological Disorders, 15, 17562864221103936. https://doi.org/10.1177/17562864221103935
Dziedzic, A., & Saluk, J. (2022). Probiotics and commensal gut microbiota as the effective alternative therapy for multiple sclerosis patients treatment. International Journal of Molecular Sciences, 23(22), 14478.
El Aidy, S., Dinan, T. G., & Cryan, J. F. (2015). Gut microbiota: the conductor in the orchestra of immune-neuroendocrine communication. Clinical Therapeutics, 37(5), 954–967. https://doi.org/10.1016/j.clinthera.2015.03.002
Engen, S. A., Valen Rukke, H., Becattini, S., Jarrossay, D., Blix, I. J., Petersen, F. C., et al. (2014). The oral commensal Streptococcus mitis shows a mixed memory Th cell signature that is similar to and cross-reactive with Streptococcus pneumoniae. PLoS ONE, 9(8), e104306. https://doi.org/10.1371/journal.pone.0104306
Ferreira-Halder, C. V., de Sousa Faria, A. V., & Andrade, S. S. (2017). Action and function of Faecalibacterium prausnitzii in health and disease. Best Practice & Research Clinical Gastroenterology, 31(6), 643–648.
Fettig, N. M., & Osborne, L. C. (2021). Direct and indirect effects of microbiota-derived metabolites on neuroinflammation in multiple sclerosis. Microbes and Infection, 23(6), 104814. https://doi.org/10.1016/j.micinf.2021.104814
Fleck, A. K., Schuppan, D., Wiendl, H., & Klotz, L. (2017). Gut-CNS-Axis as possibility to modulate inflammatory disease activity-implications for multiple sclerosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms18071526
Fransen, F., van Beek, A. A., Borghuis, T., Meijer, B., Hugenholtz, F., van der Gaast-de Jongh, C., et al. (2017). The impact of gut microbiota on gender-specific differences in immunity. Frontiers in Immunology, 8, 754.
Freedman, K. E., Hill, J. L., Wei, Y., Vazquez, A. R., Grubb, D. S., Trotter, R. E., et al. (2021). Examining the gastrointestinal and immunomodulatory effects of the novel probiotic Bacillus subtilis DE111. International Journal of Molecular Sciences, 22(5), 2453.
Fu, X., Liu, H., Huang, G., & Dai, S.-S. (2021). The emerging role of neutrophils in autoimmune-associated disorders: Effector, predictor, and therapeutic targets. MedComm, 2(3), 402–413. https://doi.org/10.1002/mco2.69
Fuchs, A., Vermi, W., Lee, J. S., Lonardi, S., Gilfillan, S., Newberry, R. D., et al. (2013). Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells. Immunity, 38(4), 769–781. https://doi.org/10.1016/j.immuni.2013.02.010
Fung, T. C., Olson, C. A., & Hsiao, E. Y. (2017). Interactions between the microbiota, immune and nervous systems in health and disease. Nature Neuroscience, 20(2), 145–155.
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., et al. (2013). Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature, 504(7480), 446–450. https://doi.org/10.1038/nature12721
Galvão, I., Tavares, L. P., Corrêa, R. O., Fachi, J. L., Rocha, V. M., Rungue, M., et al. (2018). The metabolic sensor GPR43 receptor plays a role in the control of Klebsiella pneumoniae infection in the lung. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2018.00142
Gao, H., Shu, Q., Chen, J., Fan, K., Xu, P., Zhou, Q., et al. (2019). Antibiotic exposure has sex-dependent effects on the gut microbiota and metabolism of short-chain fatty acids and amino acids in mice. Msystems. https://doi.org/10.1128/msystems
Gelfand, J. M. (2014). Chapter 12 - Multiple sclerosis: diagnosis, differential diagnosis, and clinical presentation. In D. S. Goodin (Ed.), Handbook of clinical neurology (Vol. 122, pp. 269–290): Elsevier.
Gerwien, H., Hermann, S., Zhang, X., Korpos, E., Song, J., Kopka, K., et al. (2016). Imaging matrix metalloproteinase activity in multiple sclerosis as a specific marker of leukocyte penetration of the blood-brain barrier. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aaf8020
Ghezzi, L., Cantoni, C., Pinget, G. V., Zhou, Y., & Piccio, L. (2021). Targeting the gut to treat multiple sclerosis. The Journal of Clinical Investigation. https://doi.org/10.1172/JCI143774
Ghorbani, P., Santhakumar, P., Hu, Q., Djiadeu, P., Wolever, T. M., Palaniyar, N., et al. (2015). Short-chain fatty acids affect cystic fibrosis airway inflammation and bacterial growth. European Respiratory Journal, 46(4), 1033–1045.
Gilgun-Sherki, Y., Melamed, E., & Offen, D. (2004). The role of oxidative stress in thepathogenesis of multiple sclerosis: The need for effectiveantioxidant therapy. Journal of Neurology, 251(3), 261–268. https://doi.org/10.1007/s00415-004-0348-9
Gill, P. A., van Zelm, M. C., Ffrench, R. A., Muir, J. G., & Gibson, P. R. (2020). Successful elevation of circulating acetate and propionate by dietary modulation does not alter T-regulatory cell or cytokine profiles in healthy humans: A pilot study. European Journal of Nutrition, 59, 2651–2661.
Gill, P., Van Zelm, M., Muir, J., & Gibson, P. (2018). Short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders. Alimentary Pharmacology & Therapeutics, 48(1), 15–34.
Gillard, G. O., Saenz, S. A., Huss, D. J., & Fontenot, J. D. (2016). Circulating innate lymphoid cells are unchanged in response to DAC HYP therapy. Journal of Neuroimmunology, 294, 41–45. https://doi.org/10.1016/j.jneuroim.2016.03.008
Goerdt, S., Politz, O., Schledzewski, K., Birk, R., Gratchev, A., Guillot, P., et al. (1999). Alternative versus classical activation of macrophages. Pathobiology, 67(5–6), 222–226. https://doi.org/10.1159/000028096
Gold, R., Linington, C., & Lassmann, H. (2006). Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain, 129(Pt 8), 1953–1971. https://doi.org/10.1093/brain/awl075
Golden, L. C., & Voskuhl, R. (2017). The importance of studying sex differences in disease: The example of multiple sclerosis. Journal of Neuroscience Research, 95(1–2), 633–643.
Gregory, A. P., Dendrou, C. A., Attfield, K. E., Haghikia, A., Xifara, D. K., Butter, F., et al. (2012). TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature, 488(7412), 508–511. https://doi.org/10.1038/nature11307
Griffin, W. S. (2006). Inflammation and neurodegenerative diseases. American Journal of Clinical Nutrition, 83(2), 470s–474s. https://doi.org/10.1093/ajcn/83.2.470S
Gross, C. C., Ahmetspahic, D., Ruck, T., Schulte-Mecklenbeck, A., Schwarte, K., Jörgens, S., et al. (2016). Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis. Neurology-Neuroimmunology Neuroinflammation. https://doi.org/10.1212/NXI.0000000000000289
Gross, C. C., Schulte-Mecklenbeck, A., Hanning, U., Posevitz-Fejfár, A., Korsukewitz, C., Schwab, N., et al. (2017). Distinct pattern of lesion distribution in multiple sclerosis is associated with different circulating T-helper and helper-like innate lymphoid cell subsets. Multiple Sclerosis, 23(7), 1025–1030. https://doi.org/10.1177/1352458516662726
Guerrero, B. L., & Sicotte, N. L. (2020). Microglia in multiple sclerosis: Friend or Foe? Frontiers in Immunology, 11, 374. https://doi.org/10.3389/fimmu.2020.00374
Guo, Y., Xiao, Z., Wang, Y., Yao, W., Liao, S., Yu, B., et al. (2018). Sodium butyrate ameliorates streptozotocin-induced type 1 diabetes in mice by inhibiting the HMGB1 expression. Frontiers in Endocrinology, 9, 630.
Gury-BenAri, M., Thaiss, C. A., Serafini, N., Winter, D. R., Giladi, A., Lara-Astiaso, D., et al. (2016). The spectrum and regulatory landscape of intestinal innate lymphoid cells are shaped by the microbiome. Cell. https://doi.org/10.1016/j.cell.2016.07.043
Haghikia, A., Jörg, S., Duscha, A., Berg, J., Manzel, A., Waschbisch, A., et al. (2015a). Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity, 43(4), 817–829.
Haghikia, A., Jörg, S., Duscha, A., Berg, J., Manzel, A., Waschbisch, A., et al. (2015b). Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity, 43(4), 817–829. https://doi.org/10.1016/j.immuni.2015.09.007
He, M., & Shi, B. (2017). Gut microbiota as a potential target of metabolic syndrome: The role of probiotics and prebiotics. Cell & Bioscience, 7, 54. https://doi.org/10.1186/s13578-017-0183-1
He, Y., Wu, W., Zheng, H. M., Li, P., McDonald, D., Sheng, H. F., et al. (2018). Regional variation limits applications of healthy gut microbiome reference ranges and disease models. Nature Medicine, 24(10), 1532–1535. https://doi.org/10.1038/s41591-018-0164-x
Hoban, A. E., Stilling, R. M., Ryan, F. J., Shanahan, F., Dinan, T. G., Claesson, M. J., et al. (2016). Regulation of prefrontal cortex myelination by the microbiota. Translational Psychiatry, 6(4), e774–e774. https://doi.org/10.1038/tp.2016.42
Hobbs, L., Allen, L., Bias, M., Johnson, S., DeRespiris, H., Diallo, C., et al. (2021). The opposing role of propionate in modulating listeria monocytogenes intracellular infections. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2021.721801
Hur, K. Y., & Lee, M. S. (2015). Gut microbiota and metabolic disorders. Diabetes and Metabolism Journal, 39(3), 198–203. https://doi.org/10.4093/dmj.2015.39.3.198
Illés, Z., Kondo, T., Newcombe, J., Oka, N., Tabira, T., & Yamamura, T. (2000). Differential expression of NK T Cell Vα24JαQ invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy1. The Journal of Immunology, 164(8), 4375–4381. https://doi.org/10.4049/jimmunol.164.8.4375
Jadidi-Niaragh, F., & Mirshafiey, A. (2011). Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scandinavian Journal of Immunology, 74(1), 1–13. https://doi.org/10.1111/j.1365-3083.2011.02536.x
Jäger, A., Dardalhon, V., & r., Sobel, R. A., Bettelli, E., & Kuchroo, V. K. (2009). Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes1. The Journal of Immunology, 183(11), 7169–7177. https://doi.org/10.4049/jimmunol.0901906
Jaggar, M., Rea, K., Spichak, S., Dinan, T. G., & Cryan, J. F. (2020). You’ve got male: Sex and the microbiota-gut-brain axis across the lifespan. Frontiers in Neuroendocrinology, 56, 100815.
Jain, P., Coisne, C., Enzmann, G., Rottapel, R., & Engelhardt, B. (2010). Alpha4beta1 integrin mediates the recruitment of immature dendritic cells across the blood-brain barrier during experimental autoimmune encephalomyelitis. The Journal of Immunology, 184(12), 7196–7206. https://doi.org/10.4049/jimmunol.0901404
Jakobsdottir, G., Bjerregaard, J. H., Skovbjerg, H., & Nyman, M. (2013). Fasting serum concentration of short-chain fatty acids in subjects with microscopic colitis and celiac disease: No difference compared with controls, but between genders. Scandinavian Journal of Gastroenterology, 48(6), 696–701. https://doi.org/10.3109/00365521.2013.786128
Jangi, S., Gandhi, R., Cox, L. M., Li, N., Von Glehn, F., Yan, R., et al. (2016a). Alterations of the human gut microbiome in multiple sclerosis. Nature Communications, 7(1), 12015.
Jangi, S., Gandhi, R., Cox, L. M., Li, N., von Glehn, F., Yan, R., et al. (2016b). Alterations of the human gut microbiome in multiple sclerosis. Nature Communications, 7, 12015. https://doi.org/10.1038/ncomms12015
Jantaratnotai, N., Utaisincharoen, P., Sanvarinda, P., Thampithak, A., & Sanvarinda, Y. (2013). Phytoestrogens mediated anti-inflammatory effect through suppression of IRF-1 and pSTAT1 expressions in lipopolysaccharide-activated microglia. International Immunopharmacology, 17(2), 483–488.
Ji, J.-J., Sun, Q.-M., Nie, D.-Y., Wang, Q., Zhang, H., Qin, F.-F., et al. (2021). Probiotics protect against RSV infection by modulating the microbiota-alveolar-macrophage axis. Acta Pharmacologica Sinica, 42(10), 1630–1641. https://doi.org/10.1038/s41401-020-00573-5
Kaczmarczyk, M. M., Miller, M. J., & Freund, G. G. (2012). The health benefits of dietary fiber: Beyond the usual suspects of type 2 diabetes mellitus, cardiovascular disease and colon cancer. Metabolism, 61(8), 1058–1066.
Kaliannan, K., Robertson, R. C., Murphy, K., Stanton, C., Kang, C., Wang, B., et al. (2018). Estrogen-mediated gut microbiome alterations influence sexual dimorphism in metabolic syndrome in mice. Microbiome, 6, 1–22.
Karunasena, E., McMahon, K. W., Chang, D., & Brashears, M. M. (2014). Host responses to the pathogen Mycobacterium avium subsp. paratuberculosis and beneficial microbes exhibit host sex specificity. Applied and Environmental Microbiology, 80(15), 4481–4490.
Kawachi, I., & Lassmann, H. (2017). Neurodegeneration in multiple sclerosis and neuromyelitis optica. Journal of Neurology, Neurosurgery & Psychiatry, 88(2), 137–145.
Kernbauer, E., Ding, Y., & Cadwell, K. (2014). An enteric virus can replace the beneficial function of commensal bacteria. Nature, 516(7529), 94–98. https://doi.org/10.1038/nature13960
Kespohl, M., Vachharajani, N., Luu, M., Harb, H., Pautz, S., Wolff, S., et al. (2017). The microbial metabolite butyrate induces expression of Th1-associated factors in CD4(+) T cells. Frontiers in Immunology, 8, 1036. https://doi.org/10.3389/fimmu.2017.01036
Kim, C. H., Hashimoto-Hill, S., & Kim, M. (2016). Migration and tissue tropism of innate lymphoid cells. Trends in Immunology, 37(1), 68–79. https://doi.org/10.1016/j.it.2015.11.003
Kim, N. (2022). Sex difference of gut microbiota. In N. Kim (Ed.), Sex/gender-specific medicine in the gastrointestinal diseases (pp. 363–377). Singapore: Springer Nature Singapore.
Kim, S. H., Cho, B. H., Kiyono, H., & Jang, Y. S. (2017). Microbiota-derived butyrate suppresses group 3 innate lymphoid cells in terminal ileal Peyer’s patches. Science and Reports, 7(1), 3980. https://doi.org/10.1038/s41598-017-02729-6
Kirby, T. O., & Ochoa-Repáraz, J. (2018). The gut microbiome in multiple sclerosis: a potential therapeutic avenue. Medical Science. https://doi.org/10.3390/medsci6030069
Klein Geltink, R. I., Kyle, R. L., & Pearce, E. L. (2018). Unraveling the complex interplay between T cell metabolism and function. Annual Review of Immunology, 36, 461–488.
Klein, S. L., & Flanagan, K. L. (2016). Sex differences in immune responses. Nature Reviews Immunology, 16(10), 626–638.
Kleinewietfeld, M., & Hafler, D. A. (2014). Regulatory T cells in autoimmune neuroinflammation. Immunological Reviews, 259(1), 231–244. https://doi.org/10.1111/imr.12169
Klose, C. S., Kiss, E. A., Schwierzeck, V., Ebert, K., Hoyler, T., d’Hargues, Y., et al. (2013). A T-bet gradient controls the fate and function of CCR6− RORγt+ innate lymphoid cells. Nature, 494(7436), 261–265.
Knowles, S. E., Jarrett, I. G., Filsell, O. H., & Ballard, F. J. (1974). Production and utilization of acetate in mammals. Biochemical Journal, 142(2), 401–411.
Kobayashi, T., Voisin, B., Kennedy, E. A., Jo, J.-H., Shih, H.-Y., Truong, A., et al. (2019). Homeostatic control of sebaceous glands by innate lymphoid cells regulates commensal bacteria equilibrium. Cell. https://doi.org/10.1016/j.cell.2018.12.031
Kobelt, G., Thompson, A., Berg, J., Gannedahl, M., & Eriksson, J. (2017). New insights into the burden and costs of multiple sclerosis in Europe. Multiple Sclerosis, 23(8), 1123–1136. https://doi.org/10.1177/1352458517694432
Koch-Henriksen, N., & Sørensen, P. S. (2010). The changing demographic pattern of multiple sclerosis epidemiology. The Lancet Neurology, 9(5), 520–532.
Koliada, A., Moseiko, V., Romanenko, M., Lushchak, O., Kryzhanovska, N., Guryanov, V., et al. (2021). Sex differences in the phylum-level human gut microbiota composition. BMC Microbiology, 21(1), 1–9.
Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., et al. (2006). IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis1. The Journal of Immunology, 177(1), 566–573. https://doi.org/10.4049/jimmunol.177.1.566
Kotas, M. E., & Locksley, R. M. (2018). Why innate lymphoid cells? Immunity, 48(6), 1081–1090.
Kotter, M. R., Zhao, C., van Rooijen, N., & Franklin, R. J. (2005). Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiology of Diseases, 18(1), 166–175. https://doi.org/10.1016/j.nbd.2004.09.019
Kouchaki, E., Tamtaji, O. R., Salami, M., Bahmani, F., Kakhaki, R. D., Akbari, E., et al. (2017). Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial. Clinical Nutrition, 36(5), 1245–1249.
Kozhieva, M., Naumova, N., Alikina, T., Boyko, A., Vlassov, V., & Kabilov, M. R. (2019). Primary progressive multiple sclerosis in a Russian cohort: Relationship with gut bacterial diversity. BMC Microbiology, 19(1), 1–9.
Kremenchutzky, M., Rice, G., Baskerville, J., Wingerchuk, D., & Ebers, G. (2006). The natural history of multiple sclerosis: A geographically based study 9: Observations on the progressive phase of the disease. Brain, 129(3), 584–594.
Kwon, H.-K., Kim, G.-C., Kim, Y., Hwang, W., Jash, A., Sahoo, A., et al. (2013). Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response. Clinical Immunology, 146(3), 217–227. https://doi.org/10.1016/j.clim.2013.01.001
Larsen, N., Vogensen, F. K., Gøbel, R. J., Michaelsen, K. F., Forssten, S. D., Lahtinen, S. J., et al. (2013). Effect of Lactobacillus salivarius Ls-33 on fecal microbiota in obese adolescents. Clinical Nutrition, 32(6), 935–940.
Lavasani, S., Dzhambazov, B., Nouri, M., Fåk, F., Buske, S., Molin, G., et al. (2010). A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS ONE, 5(2), e9009. https://doi.org/10.1371/journal.pone.0009009
Lawley, T. D., & Walker, A. W. (2013). Intestinal colonization resistance. Immunology, 138(1), 1–11.
Le Poul, E., Loison, C., Struyf, S., Springael, J. Y., Lannoy, V., Decobecq, M. E., et al. (2003). Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. Journal of Biological Chemistry, 278(28), 25481–25489. https://doi.org/10.1074/jbc.M301403200
Leffler, J., Trend, S., Hart, P. H., & French, M. A. (2022). Epstein-Barr virus infection, B-cell dysfunction and other risk factors converge in gut-associated lymphoid tissue to drive the immunopathogenesis of multiple sclerosis: A hypothesis. Clin Transl Immunology, 11(11), e1418. https://doi.org/10.1002/cti2.1418
Legroux, L., & Arbour, N. (2015). Multiple sclerosis and T lymphocytes: an entangled story. Journal of Neuroimmune Pharmacology, 10(4), 528–546. https://doi.org/10.1007/s11481-015-9614-0
Leppert, D., Ford, J., Stabler, G., Grygar, C., Lienert, C., Huber, S., et al. (1998). Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain: A Journal of Neurology, 121(12), 2327–2334.
Lévesque, S. A., Paré, A., Mailhot, B., Bellver-Landete, V., Kébir, H., Lécuyer, M.-A., et al. (2016). Myeloid cell transmigration across the CNS vasculature triggers IL-1β–driven neuroinflammation during autoimmune encephalomyelitis in mice. Journal of Experimental Medicine, 213(6), 929–949.
Levi, I., Gurevich, M., Perlman, G., Magalashvili, D., Menascu, S., Bar, N., et al. (2021a). Potential role of indolelactate and butyrate in multiple sclerosis revealed by integrated microbiome-metabolome analysis. Cell Reports Medicine. https://doi.org/10.1016/j.xcrm.2021.100246
Levi, I., Gurevich, M., Perlman, G., Magalashvili, D., Menascu, S., Bar, N., et al. (2021b). Potential role of indolelactate and butyrate in multiple sclerosis revealed by integrated microbiome-metabolome analysis. Cell Rep Med, 2(4), 100246. https://doi.org/10.1016/j.xcrm.2021.100246
Ley, R. E., Hamady, M., Lozupone, C., Turnbaugh, P. J., Ramey, R. R., Bircher, J. S., et al. (2008). Evolution of mammals and their gut microbes. Science, 320(5883), 1647–1651.
Li, H., Wang, P., Huang, L., Li, P., & Zhang, D. (2019). Effects of regulating gut microbiota on the serotonin metabolism in the chronic unpredictable mild stress rat model. Neurogastroenterology & Motility, 31(10), e13677.
Li, J., Doty, A. L., Iqbal, A., & Glover, S. C. (2016). The differential frequency of Lineage− CRTH2− CD45+ NKp44− CD117− CD127+ ILC subset in the inflamed terminal ileum of patients with Crohn’s disease. Cellular Immunology, 304, 63–68.
Li, Y., Zhang, B., Zhou, Y., Wang, D., Liu, X., Li, L., et al. (2020). Gut microbiota changes and their relationship with inflammation in patients with acute and chronic insomnia. Nature and Science of Sleep, 12, 895–905. https://doi.org/10.2147/nss.S271927
Liu, L., Li, L., Min, J., Wang, J., Wu, H., Zeng, Y., et al. (2012a). Butyrate interferes with the differentiation and function of human monocyte-derived dendritic cells. Cellular Immunology, 277(1), 66–73. https://doi.org/10.1016/j.cellimm.2012.05.011
Liu, L., Li, L., Min, J., Wang, J., Wu, H., Zeng, Y., et al. (2012b). Butyrate interferes with the differentiation and function of human monocyte-derived dendritic cells. Cellular Immunology, 277(1–2), 66–73. https://doi.org/10.1016/j.cellimm.2012.05.011
Liu, X., Li, X., Xia, B., Jin, X., Zou, Q., Zeng, Z., et al. (2021). High-fiber diet mitigates maternal obesity-induced cognitive and social dysfunction in the offspring via gut-brain axis. Cell Metabolism. https://doi.org/10.1016/j.cmet.2021.02.002
Lu, J., Zhang, L., Zhang, H., Chen, Y., Zhao, J., Chen, W., et al. (2023). Population-level variation in gut bifidobacterial composition and association with geography, age, ethnicity, and staple food. Npj Biofilms and Microbiomes, 9(1), 98.
Luczynski, P., Whelan, S. O., O’Sullivan, C., Clarke, G., Shanahan, F., Dinan, T. G., et al. (2016). Adult microbiota-deficient mice have distinct dendritic morphological changes: Differential effects in the amygdala and hippocampus. European Journal of Neuroscience, 44(9), 2654–2666. https://doi.org/10.1111/ejn.13291
Luethy, P. M., Huynh, S., Ribardo, D. A., Winter, S. E., Parker, C. T., & Hendrixson, D. R. (2017). Microbiota-derived short-chain fatty acids modulate expression of Campylobacter jejuni determinants required for commensalism and virulence. Mbio. https://doi.org/10.1128/mbio
Lundmark, F., Duvefelt, K., Iacobaeus, E., Kockum, I., Wallström, E., Khademi, M., et al. (2007). Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nature Genetics, 39(9), 1108–1113. https://doi.org/10.1038/ng2106
Luu, M., Pautz, S., Kohl, V., Singh, R., Romero, R., Lucas, S., et al. (2019). The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes. Nature Communications, 10(1), 760. https://doi.org/10.1038/s41467-019-08711-2
Maa, M.-C., Chang, M. Y., Hsieh, M.-Y., Chen, Y.-J., Yang, C.-J., Chen, Z.-C., et al. (2010). Butyrate reduced lipopolysaccharide-mediated macrophage migration by suppression of Src enhancement and focal adhesion kinase activity. The Journal of Nutritional Biochemistry, 21(12), 1186–1192.
Macfarlane, S., & Macfarlane, G. T. (2003a). Regulation of short-chain fatty acid production. Proceedings of the Nutrition Society, 62(1), 67–72.
Macfarlane, S., & Macfarlane, G. T. (2003b). Regulation of short-chain fatty acid production. The Proceedings of the Nutrition Society, 62(1), 67–72. https://doi.org/10.1079/pns2002207
Mackley, E. C., Houston, S., Marriott, C. L., Halford, E. E., Lucas, B., Cerovic, V., et al. (2015). CCR7-dependent trafficking of RORγ+ ILCs creates a unique microenvironment within mucosal draining lymph nodes. Nature Communications, 6(1), 5862. https://doi.org/10.1038/ncomms6862
Maier, L. M., Lowe, C. E., Cooper, J., Downes, K., Anderson, D. E., Severson, C., et al. (2009). IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PLoS Genetics, 5(1), e1000322. https://doi.org/10.1371/journal.pgen.1000322
Manousaki, D., Dudding, T., Haworth, S., Hsu, Y.-H., Liu, C.-T., Medina-Gómez, C., et al. (2017). Low-frequency synonymous coding variation in CYP2R1 has large effects on vitamin D levels and risk of multiple sclerosis. The American Journal of Human Genetics, 101(2), 227–238.
Mariño, E., Richards, J. L., McLeod, K. H., Stanley, D., Yap, Y. A., Knight, J., et al. (2017). Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes. Nature Immunology, 18(5), 552–562.
Markle, J. G., Frank, D. N., Mortin-Toth, S., Robertson, C. E., Feazel, L. M., Rolle-Kampczyk, U., et al. (2013). Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science, 339(6123), 1084–1088.
Martin-Gallausiaux, C., Marinelli, L., Blottière, H. M., Larraufie, P., & Lapaque, N. (2021). SCFA: Mechanisms and functional importance in the gut. Proceedings of the Nutrition Society, 80(1), 37–49.
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Di, Y., et al. (2009a). Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature, 461(7268), 1282–1286. https://doi.org/10.1038/nature08530
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., et al. (2009b). Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature, 461(7268), 1282–1286.
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., et al. (2009c). Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature, 461(7268), 1282–1286. https://doi.org/10.1038/nature08530
McCarthy, M. M., Pickett, L. A., VanRyzin, J. W., & Kight, K. E. (2015). Surprising origins of sex differences in the brain. Hormones and Behavior, 76, 3–10.
McDonald, D., Hyde, E., Debelius, J. W., Morton, J. T., Gonzalez, A., Ackermann, G., et al. (2018). American gut: an open platform for citizen science microbiome research. mSystems. https://doi.org/10.1128/mSystems.00031-18
McGinley, A. M., Sutton, C. E., Edwards, S. C., Leane, C. M., DeCourcey, J., Teijeiro, A., et al. (2020). Interleukin-17A serves a priming role in autoimmunity by recruiting IL-1β-producing myeloid cells that promote pathogenic T cells. Immunity. https://doi.org/10.1016/j.immuni.2020.01.002
Mekky, J., Wani, R., Said, S. M., Ashry, M., Ibrahim, A. E., & Ahmed, S. M. (2022). Molecular characterization of the gut microbiome in egyptian patients with remitting relapsing multiple sclerosis. Mult Scler Relat Disord, 57, 103354. https://doi.org/10.1016/j.msard.2021.103354
Melbye, P., Olsson, A., Hansen, T. H., Søndergaard, H. B., & Bang Oturai, A. (2019a). Short-chain fatty acids and gut microbiota in multiple sclerosis. Acta Neurologica Scandinavica, 139(3), 208–219. https://doi.org/10.1111/ane.13045
Melbye, P., Olsson, A., Hansen, T. H., Søndergaard, H. B., & Bang Oturai, A. (2019b). Short-chain fatty acids and gut microbiota in multiple sclerosis. Acta Neurologica Scandinavica, 139(3), 208–219.
Minohara, M., Matsuoka, T., Li, W., Osoegawa, M., Ishizu, T., Ohyagi, Y., et al. (2006). Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: Positive correlation with disease severity. Journal of Neuroimmunology, 178(1–2), 156–160.
Mirmonsef, P., Zariffard, M. R., Gilbert, D., Makinde, H., Landay, A. L., & Spear, G. T. (2012). Short-chain fatty acids induce pro-inflammatory cytokine production alone and in combination with toll-like receptor ligands. American Journal of Reproductive Immunology, 67(5), 391–400.
Miyake, S., Kim, S., Suda, W., Oshima, K., Nakamura, M., Matsuoka, T., et al. (2015). Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters. PLoS ONE, 10(9), e0137429.
Mizuno, M., Noto, D., Kaga, N., Chiba, A., & Miyake, S. (2017). The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models. PLoS ONE, 12(2), e0173032.
Mohammadi, A. A., Jazayeri, S., Khosravi-Darani, K., Solati, Z., Mohammadpour, N., Asemi, Z., et al. (2016). The effects of probiotics on mental health and hypothalamic–pituitary–adrenal axis: A randomized, double-blind, placebo-controlled trial in petrochemical workers. Nutritional Neuroscience, 19(9), 387–395.
Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., et al. (2002). Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature, 415(6871), 536–541. https://doi.org/10.1038/415536a
Moore, S. (2013). Major depression and multiple sclerosis—a case report. Journal of Medicine and Life, 6(3), 290–291.
Morante-Palacios, O., Fondelli, F., Ballestar, E., & Martínez-Cáceres, E. M. (2021). Tolerogenic dendritic cells in autoimmunity and inflammatory diseases. Trends in Immunology, 42(1), 59–75. https://doi.org/10.1016/j.it.2020.11.001
Mu, Q., Zhang, H., Liao, X., Lin, K., Liu, H., Edwards, M. R., et al. (2017). Control of lupus nephritis by changes of gut microbiota. Microbiome, 5(1), 1–12.
Mueller, S., Saunier, K., Hanisch, C., Norin, E., Alm, L., Midtvedt, T., et al. (2006). Differences in fecal microbiota in different European study populations in relation to age, gender, and country: A cross-sectional study. Applied and Environmental Microbiology, 72(2), 1027–1033.
Müller-Ladner, U., Jones, J. L., Wetsel, R. A., Gay, S., Raine, C. S., & Barnum, S. R. (1996). Enhanced expression of chemotactic receptors in multiple sclerosis lesions. Journal of the Neurological Sciences, 144(1–2), 135–141. https://doi.org/10.1016/s0022-510x(96)00217-1
Murphy, J. M., Ngai, L., Mortha, A., & Crome, S. Q. (2022). Tissue-dependent adaptations and functions of innate lymphoid cells. Frontiers in Immunology, 13, 836999. https://doi.org/10.3389/fimmu.2022.836999
Naegele, M., Tillack, K., Reinhardt, S., Schippling, S., Martin, R., & Sospedra, M. (2012). Neutrophils in multiple sclerosis are characterized by a primed phenotype. Journal of Neuroimmunology, 242(1–2), 60–71.
Nakanishi, N., Tashiro, K., Kuhara, S., Hayashi, T., Sugimoto, N., & Tobe, T. (2009). Regulation of virulence by butyrate sensing in enterohaemorrhagic Escherichia coli. Microbiology, 155(2), 521–530.
Nastasi, C., Candela, M., Bonefeld, C. M., Geisler, C., Hansen, M., Krejsgaard, T., et al. (2015). The effect of short-chain fatty acids on human monocyte-derived dendritic cells. Scientific Reports, 5(1), 16148. https://doi.org/10.1038/srep16148
Nastasi, C., Fredholm, S., Willerslev-Olsen, A., Hansen, M., Bonefeld, C. M., Geisler, C., et al. (2017). Butyrate and propionate inhibit antigen-specific CD8(+) T cell activation by suppressing IL-12 production by antigen-presenting cells. Science and Reports, 7(1), 14516. https://doi.org/10.1038/s41598-017-15099-w
Nouri, M., Bredberg, A., Weström, B., & Lavasani, S. (2014). Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells. PLoS ONE, 9(9), e106335.
Obradovic, D., Andjelic, T., Ninkovic, M., Dejanovic, B., & Kotur-Stevuljevic, J. (2021). Superoxide dismutase (SOD), advanced oxidation protein products (AOPP), and disease-modifying treatment are related to better relapse recovery after corticosteroid treatment in multiple sclerosis. Neurological Sciences, 42, 3241–3247.
Ochel, A., Tiegs, G., & Neumann, K. (2019). Type 2 innate lymphoid cells in liver and gut: from current knowledge to future perspectives. International Journal of Molecular Sciences, 20(8), 1896.
Ochoa-Repáraz, J., Mielcarz, D. W., Ditrio, L. E., Burroughs, A. R., Foureau, D. M., Haque-Begum, S., et al. (2009). Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis1. The Journal of Immunology, 183(10), 6041–6050. https://doi.org/10.4049/jimmunol.0900747
Ogbonnaya, E. S., Clarke, G., Shanahan, F., Dinan, T. G., Cryan, J. F., & O’Leary, O. F. (2015). Adult hippocampal neurogenesis is regulated by the microbiome. Biological Psychiatry, 78(4), e7-9. https://doi.org/10.1016/j.biopsych.2014.12.023
Ohnmacht, C., Pullner, A., King, S. B., Drexler, I., Meier, S., Brocker, T., et al. (2009). Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. Journal of Experimental Medicine, 206(3), 549–559. https://doi.org/10.1084/jem.20082394
Okuda, D. T., Siva, A., Kantarci, O., Inglese, M., Katz, I., Tutuncu, M., et al. (2014). Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS ONE, 9(3), e90509. https://doi.org/10.1371/journal.pone.0090509
Ordoñez-Rodriguez, A., Roman, P., Rueda-Ruzafa, L., Campos-Rios, A., & Cardona, D. (2023). Changes in gut microbiota and multiple sclerosis: a systematic review. International Journal of Environmental Research and Public Health, 20(5), 4624.
O’Riordan, K. J., Collins, M. K., Moloney, G. M., Knox, E. G., Aburto, M. R., Fülling, C., et al. (2022). Short chain fatty acids: Microbial metabolites for gut-brain axis signalling. Molecular and Cellular Endocrinology, 546, 111572. https://doi.org/10.1016/j.mce.2022.111572
Pakpoor, J., Handel, A. E., Giovannoni, G., Dobson, R., & Ramagopalan, S. V. (2012). Meta-analysis of the relationship between multiple sclerosis and migraine. PLoS ONE. https://doi.org/10.1371/journal.pone.0045295
Panda, S. K., & Colonna, M. (2019a). Innate lymphoid cells in mucosal immunity. Frontiers in Immunology, 10, 861.
Panda, S. K., & Colonna, M. (2019b). Innate lymphoid cells in mucosal immunity. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2019.00861
Paré, A., Mailhot, B., Lévesque, S. A., & Lacroix, S. (2017). Involvement of the IL-1 system in experimental autoimmune encephalomyelitis and multiple sclerosis: Breaking the vicious cycle between IL-1β and GM-CSF. Brain, Behavior, and Immunity, 62, 1–8.
Park, J., & Kim, C. H. (2021). Regulation of common neurological disorders by gut microbial metabolites. Experimental & Molecular Medicine, 53(12), 1821–1833. https://doi.org/10.1038/s12276-021-00703-x
Park, J., Wang, Q., Wu, Q., Mao-Draayer, Y., & Kim, C. H. (2019). Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation. Scientific Reports, 9(1), 8837.
Patel, P. G., Patel, A. C., Chakraborty, P., & Gosai, H. B. (2023). Impact of Dietary Habits, Ethnicity, and Geographical Provenance in Shaping Human Gut Microbiome Diversity. In Probiotics, Prebiotics, Synbiotics, and Postbiotics: Human Microbiome and Human Health (pp. 3–27): Springer.
Paterka, M., Siffrin, V., Voss, J. O., Werr, J., Hoppmann, N., Gollan, R., et al. (2016). Gatekeeper role of brain antigen-presenting CD11c+ cells in neuroinflammation. EMBO Journal, 35(1), 89–101. https://doi.org/10.15252/embj.201591488
Pelletier, M., Maggi, L., Micheletti, A., Lazzeri, E., Tamassia, N., Costantini, C., et al. (2010). Evidence for a cross-talk between human neutrophils and Th17 cells. Blood, 115(2), 335–343. https://doi.org/10.1182/blood-2009-04-216085
Pérez-Pérez, S., Domínguez-Mozo, M. I., Alonso-Gómez, A., Medina, S., Villarrubia, N., Fernández-Velasco, J. I., et al. (2020). Acetate correlates with disability and immune response in multiple sclerosis. PeerJ, 8, e10220.
Piekarska, J., Miśta, D., Houszka, M., Kroliczewska, B., Zawadzki, W., & Gorczykowski, M. (2011). Trichinella spiralis: The influence of short chain fatty acids on the proliferation of lymphocytes, the goblet cell count and apoptosis in the mouse intestine. Experimental Parasitology, 128(4), 419–426.
Plichta, D. R., Graham, D. B., Subramanian, S., & Xavier, R. J. (2019). Therapeutic opportunities in inflammatory bowel disease: Mechanistic dissection of host-microbiome relationships. Cell, 178(5), 1041–1056.
Powell, N., Walker, A. W., Stolarczyk, E., Canavan, J. B., Gökmen, M. R., Marks, E., et al. (2012). The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells. Immunity, 37(4), 674–684.
Prosberg, M., Bendtsen, F., Vind, I., Petersen, A. M., & Gluud, L. L. (2016). The association between the gut microbiota and the inflammatory bowel disease activity: A systematic review and meta-analysis. Scandinavian Journal of Gastroenterology, 51(12), 1407–1415. https://doi.org/10.1080/00365521.2016.1216587
Rahimlou, M., Hosseini, S. A., Majdinasab, N., Haghighizadeh, M. H., & Husain, D. (2022). Effects of long-term administration of Multi-Strain Probiotic on circulating levels of BDNF, NGF, IL-6 and mental health in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial. Nutritional Neuroscience, 25(2), 411–422.
Rajilić-Stojanović, M., Biagi, E., Heilig, H. G., Kajander, K., Kekkonen, R. A., Tims, S., et al. (2011). Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology, 141(5), 1792–1801. https://doi.org/10.1053/j.gastro.2011.07.043
Raqib, R., Sarker, P., Bergman, P., Ara, G., Lindh, M., Sack, D. A., et al. (2006). Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proceedings of the National Academy of Sciences, 103(24), 9178–9183.
Rauf, A., Khalil, A. A., Rahman, U.-u.-., Khalid, A., Naz, S., Shariati, M. A., et al. (2022). Recent advances in the therapeutic application of short-chain fatty acids (SCFAs): An updated review. Critical Reviews in Food Science and Nutrition, 62(22), 6034–6054.
Rawji, K. S., & Yong, V. W. (2013). The benefits and detriments of macrophages/microglia in models of multiple sclerosis. Clinical and Developmental Immunology, 2013, 948976. https://doi.org/10.1155/2013/948976
Rekha, K., Venkidasamy, B., Samynathan, R., Nagella, P., Rebezov, M., Khayrullin, M., et al. (2022). Short-chain fatty acid: An updated review on signaling, metabolism, and therapeutic effects. Critical Reviews in Food Science and Nutrition. https://doi.org/10.1080/10408398.2022.2124231
Rennick, D., Berg, D., & Holland, G. (1992). Interleukin 10: An overview. Progress in Growth Factor Research, 4(3), 207–227.
Reynders, A., Yessaad, N., Vu Manh, T.-P., Dalod, M., Fenis, A., Aubry, C., et al. (2011). Identity, regulation and in vivo function of gut NKp46+RORγt+ and NKp46+RORγt− lymphoid cells. The EMBO Journal, 30(14), 2934–2947. https://doi.org/10.1038/emboj.2011.201
Reynders, T., Devolder, L., Valles-Colomer, M., Van Remoortel, A., Joossens, M., De Keyser, J., et al. (2020). Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes. Annals of Clinical Translational Neurology, 7(4), 406–419. https://doi.org/10.1002/acn3.51004
Ríos-Covián, D., Ruas-Madiedo, P., Margolles, A., Gueimonde, M., de Los Reyes-Gavilán, C. G., & Salazar, N. (2016). Intestinal short chain fatty acids and their link with diet and human health. Frontiers in Microbiology, 7, 185. https://doi.org/10.3389/fmicb.2016.00185
Roger, T., Lugrin, J., Le Roy, D., Goy, G., Mombelli, M., Koessler, T., et al. (2011). Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. Blood, the Journal of the American Society of Hematology, 117(4), 1205–1217.
Rogers, G., Keating, D. J., Young, R. L., Wong, M.-L., Licinio, J., & Wesselingh, S. (2016). From gut dysbiosis to altered brain function and mental illness: Mechanisms and pathways. Molecular Psychiatry, 21(6), 738–748.
Ross, E. A., Devitt, A., & Johnson, J. R. (2021). Macrophages: The good, the bad, and the gluttony. Frontiers in Immunology, 12, 708186.
Rossi, O., Van Berkel, L. A., Chain, F., Tanweer Khan, M., Taverne, N., Sokol, H., et al. (2016). Faecalibacterium prausnitzii A2–165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses. Scientific Reports, 6(1), 18507.
Ruggieri, S., Petracca, M., De Giglio, L., De Luca, F., Giannì, C., Gurreri, F., et al. (2021). A matter of atrophy: Differential impact of brain and spine damage on disability worsening in multiple sclerosis. Journal of Neurology, 268(12), 4698–4706.
Salami, M., Kouchaki, E., Asemi, Z., & Tamtaji, O. R. (2019). How probiotic bacteria influence the motor and mental behaviors as well as immunological and oxidative biomarkers in multiple sclerosis? A double blind clinical trial. Journal of Functional Foods, 52, 8–13.
Salehipour, Z., Haghmorad, D., Sankian, M., Rastin, M., Nosratabadi, R., Dallal, M. M. S., et al. (2017). Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance. Biomedicine & Pharmacotherapy, 95, 1535–1548.
Sánchez, B., Delgado, S., Blanco-Míguez, A., Lourenço, A., Gueimonde, M., & Margolles, A. (2017). Probiotics, gut microbiota, and their influence on host health and disease. Molecular Nutrition & Food Research, 61(1), 1600240.
Sandoval, A., Triviños, F., Sanhueza, A., Carretta, D., Hidalgo, M. A., Hancke, J. L., et al. (2007). Propionate induces pH(i) changes through calcium flux, ERK1/2, p38, and PKC in bovine neutrophils. Veterinary Immunology and Immunopathology, 115(3–4), 286–298. https://doi.org/10.1016/j.vetimm.2006.11.003
Sanna, S., van Zuydam, N. R., Mahajan, A., Kurilshikov, A., Vich Vila, A., Võsa, U., et al. (2019). Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nature Genetics, 51(4), 600–605. https://doi.org/10.1038/s41588-019-0350-x
Santos-Marcos, J. A., Rangel-Zuñiga, O. A., Jimenez-Lucena, R., Quintana-Navarro, G. M., Garcia-Carpintero, S., Malagon, M. M., et al. (2018). Influence of gender and menopausal status on gut microbiota. Maturitas, 116, 43–53.
Saresella, M., Marventano, I., Barone, M., La Rosa, F., Piancone, F., Mendozzi, L., et al. (2020). Alterations in circulating fatty acid are associated with gut microbiota dysbiosis and inflammation in multiple sclerosis. Frontiers in Immunology, 11, 1390.
Sarkola, T., Iles, M. R., Kohlenberg-Mueller, K., & Eriksson, C. P. (2002). Ethanol, acetaldehyde, acetate, and lactate levels after alcohol intake in white men and women: effect of 4-methylpyrazole. Alcoholism: Clinical and Experimental Research, 26(2), 239–245.
Satoh-Takayama, N., Vosshenrich, C. A., Lesjean-Pottier, S., Sawa, S., Lochner, M., Rattis, F., et al. (2008). Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity, 29(6), 958–970.
Sawa, S., Lochner, M., Satoh-Takayama, N., Dulauroy, S., Bérard, M., Kleinschek, M., et al. (2011). RORγt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nature Immunology, 12(4), 320–326. https://doi.org/10.1038/ni.2002
Scheppach, W. (1994). Effects of short chain fatty acids on gut morphology and function. Gut, 35(1 Suppl), S35–S38.
Scher, J. U., Ubeda, C., Artacho, A., Attur, M., Isaac, S., Reddy, S. M., et al. (2015). Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis & Rhematology, 67(1), 128–139. https://doi.org/10.1002/art.38892
Schoeps, V. A., Zhou, X., Horton, M. K., Zhu, F., McCauley, K. E., Nasr, Z., et al. (2024). Short-chain fatty acid producers in the gut are associated with pediatric multiple sclerosis onset. Annals of Clinical and Translational Neurology, 11(1), 169–184. https://doi.org/10.1002/acn3.51944
Schreibelt, G., van Horssen, J., van Rossum, S., Dijkstra, C. D., Drukarch, B., & de Vries, H. E. (2007). Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Research Reviews, 56(2), 322–330. https://doi.org/10.1016/j.brainresrev.2007.07.005
Schulthess, J., Pandey, S., Capitani, M., Rue-Albrecht, K., Arnold, I., Franchini, F., et al. (2019a). The short chain fatty acid butyrate imprints an antimicrobial program in macrophages. Immunity. https://doi.org/10.1016/j.immuni.2018.12.018
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., et al. (2010). Microbiota and SCFA in lean and overweight healthy subjects. Obesity (silver Spring), 18(1), 190–195. https://doi.org/10.1038/oby.2009.167
Secher, T., Kassem, S., Benamar, M., Bernard, I., Boury, M., Barreau, F., et al. (2017). Oral administration of the probiotic strain Escherichia coli Nissle 1917 reduces susceptibility to neuroinflammation and repairs experimental autoimmune encephalomyelitis-induced intestinal barrier dysfunction. Frontiers in Immunology, 8, 1096.
Seehus, C. R., Kadavallore, A., Torre, B., d. l., Yeckes, A. R., Wang, Y., Tang, J., et al. (2017). Alternative activation generates IL-10 producing type 2 innate lymphoid cells. Nature Communications, 8(1), 1900.
Sencio, V., Barthelemy, A., Tavares, L. P., Machado, M. G., Soulard, D., Cuinat, C., et al. (2020). Gut dysbiosis during influenza contributes to pulmonary pneumococcal superinfection through altered short-chain fatty acid production. Cell Reports, 30(9), 2934-2947.e2936. https://doi.org/10.1016/j.celrep.2020.02.013
Sepahi, A., Liu, Q., Friesen, L., & Kim, C. H. (2021). Dietary fiber metabolites regulate innate lymphoid cell responses. Mucosal Immunology, 14(2), 317–330. https://doi.org/10.1038/s41385-020-0312-8
Shahi, S. K., Freedman, S. N., & Mangalam, A. K. (2017). Gut microbiome in multiple sclerosis: The players involved and the roles they play. Gut Microbes, 8(6), 607–615.
Shahinas, D., Silverman, M., Sittler, T., Chiu, C., Kim, P., Allen-Vercoe, E., et al. (2012). Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing. MBio, 3(5), https://doi.org/10.1128/mbio. 00338–00312.
Shastri, P., McCarville, J., Kalmokoff, M., Brooks, S. P., & Green-Johnson, J. M. (2015). Sex differences in gut fermentation and immune parameters in rats fed an oligofructose-supplemented diet. Biology of Sex Differences, 6, 1–12.
Shen, G., Wu, J., Ye, B.-C., & Qi, N. (2021). Gut microbiota-derived metabolites in the development of diseases. Canadian Journal of Infectious Diseases and Medical Microbiology, 2021, 6658674. https://doi.org/10.1155/2021/6658674
Sherman, S. B., Sarsour, N., Salehi, M., Schroering, A., Mell, B., Joe, B., et al. (2018). Prenatal androgen exposure causes hypertension and gut microbiota dysbiosis. Gut Microbes, 9(5), 400–421.
Shi, T. T., Xin, Z., Hua, L., Zhao, R. X., Yang, Y. L., Wang, H., et al. (2019). Alterations in the intestinal microbiota of patients with severe and active Graves’ orbitopathy: A cross-sectional study. Journal of Endocrinological Investigation, 42(8), 967–978. https://doi.org/10.1007/s40618-019-1010-9
Shibata, F., Konishi, K., Kato, H., Komorita, N., al-Mokdad, M., Fujioka, M., et al. (1995). Recombinant production and biological properties of rat cytokine-induced neutrophil chemoattractants, GRO/CINC-2 alpha, CINC-2 beta and CINC-3. European Journal of Biochemistry, 231(2), 306–311. https://doi.org/10.1111/j.1432-1033.1995.tb20701.x
Silva, Y. P., Bernardi, A., & Frozza, R. L. (2020). The role of short-chain fatty acids from gut microbiota in gut-brain communication. Frontiers in Endocrinology (lausanne), 11, 25. https://doi.org/10.3389/fendo.2020.00025
Silveira, C., Guedes, R., Maia, D., Curral, R., & Coelho, R. (2019). Neuropsychiatric symptoms of multiple sclerosis: State of the art. Psychiatry Investigation, 16(12), 877.
Singh, N., Thangaraju, M., Prasad, P. D., Martin, P. M., Lambert, N. A., Boettger, T., et al. (2010). Blockade of dendritic cell development by bacterial fermentation products butyrate and propionate through a transporter (Slc5a8)-dependent inhibition of histone deacetylases. Journal of Biological Chemistry, 285(36), 27601–27608.
Singh, R. K., Chang, H.-W., Yan, D., Lee, K. M., Ucmak, D., Wong, K., et al. (2017). Influence of diet on the gut microbiome and implications for human health. Journal of Translational Medicine, 15(1), 1–17.
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly, Y. M., et al. (2013b). The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science, 341(6145), 569–573. https://doi.org/10.1126/science.1241165
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-y, M., et al. (2013a). The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science, 341(6145), 569–573.
Steri, M., Orrù, V., Idda, M. L., Pitzalis, M., Pala, M., Zara, I., et al. (2017). Overexpression of the cytokine BAFF and autoimmunity risk. New England Journal of Medicine, 376(17), 1615–1626. https://doi.org/10.1056/NEJMoa1610528
Sun, Y., Wilkinson, B. J., Standiford, T. J., Akinbi, H. T., & O’Riordan, M. X. (2012). Fatty acids regulate stress resistance and virulence factor production for Listeria monocytogenes. Journal of Bacteriology, 194(19), 5274–5284.
Tabas, I. (2005). Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: The importance of lesion stage and phagocytic efficiency. Arteriosclerosis, Thrombosis, and Vascular Biology, 25(11), 2255–2264. https://doi.org/10.1161/01.ATV.0000184783.04864.9f
Taggart, A. K., Kero, J., Gan, X., Cai, T. Q., Cheng, K., Ippolito, M., et al. (2005). (D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. Journal of Biological Chemistry, 280(29), 26649–26652. https://doi.org/10.1074/jbc.C500213200
Takagi, T., Naito, Y., Inoue, R., Kashiwagi, S., Uchiyama, K., Mizushima, K., et al. (2019). Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects. Journal of Gastroenterology, 54, 53–63.
Tamtaji, O. R., Kouchaki, E., Salami, M., Aghadavod, E., Akbari, E., Tajabadi-Ebrahimi, M., et al. (2017). The effects of probiotic supplementation on gene expression related to inflammation, insulin, and lipids in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial. Journal of the American College of Nutrition, 36(8), 660–665.
Tan, J., McKenzie, C., Potamitis, M., Thorburn, A. N., Mackay, C. R., & Macia, L. (2014a). The role of short-chain fatty acids in health and disease. Advances in Immunology, 121, 91–119. https://doi.org/10.1016/b978-0-12-800100-4.00003-9
Tan, J., McKenzie, C., Potamitis, M., Thorburn, A. N., Mackay, C. R., & Macia, L. (2014b). The role of short-chain fatty acids in health and disease. Advances in Immunology, 121, 91–119.
Tankou, S. K., Regev, K., Healy, B. C., Cox, L. M., Tjon, E., Kivisakk, P., et al. (2018a). Investigation of probiotics in multiple sclerosis. Multiple Sclerosis Journal, 24(1), 58–63.
Tankou, S. K., Regev, K., Healy, B. C., Tjon, E., Laghi, L., Cox, L. M., et al. (2018b). A probiotic modulates the microbiome and immunity in multiple sclerosis. Annals of Neurology, 83(6), 1147–1161.
Tao, R., De Zoeten, E. F., Özkaynak, E., Chen, C., Wang, L., Porrett, P. M., et al. (2007). Deacetylase inhibition promotes the generation and function of regulatory T cells. Nature Medicine, 13(11), 1299–1307.
Tedelind, S., Westberg, F., Kjerrulf, M., & Vidal, A. (2007a). Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: A study with relevance to inflammatory bowel disease. World Journal of Gastroenterology, 13(20), 2826–2832. https://doi.org/10.3748/wjg.v13.i20.2826
Tedelind, S., Westberg, F., Kjerrulf, M., & Vidal, A. (2007b). Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: A study with relevance to inflammatory bowel disease. World Journal of Gastroenterology: WJG, 13(20), 2826.
Tejesvi, M. V., Arvonen, M., Kangas, S. M., Keskitalo, P. L., Pirttilä, A. M., Karttunen, T. J., et al. (2016). Faecal microbiome in new-onset juvenile idiopathic arthritis. European Journal of Clinical Microbiology and Infectious Diseases, 35(3), 363–370. https://doi.org/10.1007/s10096-015-2548-x
Thio, C.L.-P., Chi, P.-Y., Lai, A.C.-Y., & Chang, Y.-J. (2018a). Regulation of type 2 innate lymphoid cell–dependent airway hyperreactivity by butyrate. Journal of Allergy and Clinical Immunology, 142(6), 1867-1883.e1812. https://doi.org/10.1016/j.jaci.2018.02.032
Thio, C.L.-P., Chi, P.-Y., Lai, A.C.-Y., & Chang, Y.-J. (2018b). Regulation of type 2 innate lymphoid cell–dependent airway hyperreactivity by butyrate. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2018.02.032
Thion, M. S., Low, D., Silvin, A., Chen, J., Grisel, P., Schulte-Schrepping, J., et al. (2018). Microbiome influences prenatal and adult microglia in a sex-specific manner. Cell. https://doi.org/10.1016/j.cell.2017.11.042
Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G., et al. (2018). Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet Neurology, 17(2), 162–173.
Tian, X., Hellman, J., Horswill, A. R., Crosby, H. A., Francis, K. P., & Prakash, A. (2019). Elevated gut microbiome-derived propionate levels are associated with reduced sterile lung inflammation and bacterial immunity in mice. Frontiers in Microbiology, 10, 159.
Trapecar, M., Communal, C., Velazquez, J., Maass, C. A., Huang, Y.-J., Schneider, K., et al. (2020). Gut-liver physiomimetics reveal paradoxical modulation of IBD-related inflammation by short-chain fatty acids. Cell Systems. https://doi.org/10.1016/j.cels.2020.02.008
Tremlett, H., Fadrosh, D. W., Faruqi, A. A., Hart, J., Roalstad, S., Graves, J., et al. (2016a). Gut microbiota composition and relapse risk in pediatric MS: A pilot study. Journal of the Neurological Sciences, 363, 153–157. https://doi.org/10.1016/j.jns.2016.02.042
Tremlett, H., Fadrosh, D. W., Faruqi, A. A., Hart, J., Roalstad, S., Graves, J., et al. (2016b). Gut microbiota composition and relapse risk in pediatric MS: A pilot study. Journal of the Neurological Sciences, 363, 153–157.
Trompette, A., Gollwitzer, E. S., Yadava, K., Sichelstiel, A. K., Sprenger, N., Ngom-Bru, C., et al. (2014). Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nature Medicine, 20(2), 159–166. https://doi.org/10.1038/nm.3444
Valdearcos, M., Esquinas, E., Meana, C., Peña, L., Gil-de-Gómez, L., Balsinde, J., et al. (2012). Lipin-2 reduces proinflammatory signaling induced by saturated fatty acids in macrophages. Journal of Biological Chemistry, 287(14), 10894–10904. https://doi.org/10.1074/jbc.M112.342915
van der Hee, B., & Wells, J. M. (2021). Microbial regulation of host physiology by short-chain fatty acids. Trends in Microbiology, 29(8), 700–712.
Van Kaer, L., Postoak, J. L., Wang, C., Yang, G., & Wu, L. (2019). Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE. Cellular & Molecular Immunology, 16(6), 531–539. https://doi.org/10.1038/s41423-019-0221-5
Vanderhaeghen, S., Lacroix, C., & Schwab, C. (2015). Methanogen communities in stools of humans of different age and health status and co-occurrence with bacteria. FEMS Microbiology Letters. https://doi.org/10.1093/femsle/fnv092
Ventura, R., Iizumi, T., Battaglia, T., Liu, M., Perez-Perez, G., Herbert, J., et al. (2019). Gut microbiome of treatment-naïve MS patients of different ethnicities early in disease course. Scientific Reports, 9(1), 16396.
Verhaar, B. J. H., Hendriksen, H. M. A., de Leeuw, F. A., Doorduijn, A. S., van Leeuwenstijn, M., Teunissen, C. E., et al. (2021). Gut microbiota composition is related to AD pathology. Frontiers in Immunology, 12, 794519. https://doi.org/10.3389/fimmu.2021.794519
Vinolo, M. A., Hatanaka, E., Lambertucci, R. H., Newsholme, P., & Curi, R. (2009). Effects of short chain fatty acids on effector mechanisms of neutrophils. Cell Biochemistry and Function, 27(1), 48–55. https://doi.org/10.1002/cbf.1533
Vinolo, M. A., Rodrigues, H. G., Hatanaka, E., Sato, F. T., Sampaio, S. C., & Curi, R. (2011). Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. Journal of Nutritional Biochemistry, 22(9), 849–855. https://doi.org/10.1016/j.jnutbio.2010.07.009
Vivier, E., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J. P., Eberl, G., et al. (2018). Innate lymphoid cells: 10 years on. Cell, 174(5), 1054–1066.
Von Moltke, J., Ji, M., Liang, H.-E., & Locksley, R. M. (2016). Tuft-cell-derived IL-25 regulates an intestinal ILC2–epithelial response circuit. Nature, 529(7585), 221–225.
Walton, C., King, R., Rechtman, L., Kaye, W., Leray, E., Marrie, R. A., et al. (2020). Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Multiple Sclerosis Journal, 26(14), 1816–1821.
Wanders, D., Graff, E. C., & Judd, R. L. (2012). Effects of high fat diet on GPR109A and GPR81 gene expression. Biochemical and Biophysical Research Communications, 425(2), 278–283. https://doi.org/10.1016/j.bbrc.2012.07.082
Wang, C., Yang, J., Xie, L., Saimaier, K., Zhuang, W., Han, M., et al. (2022). Methyl butyrate alleviates experimental autoimmune encephalomyelitis and regulates the balance of effector T cells and regulatory T cells. Inflammation, 45(3), 977–991. https://doi.org/10.1007/s10753-021-01596-8
Weinshenker, B. G., Bass, B., Rice, G. P. A., Noseworthy, J., Carriere, W., Baskerville, J., et al. (1989). The natural history of multiple sclerosis: a geographically based study: I clinical course and disability. Brain, 112(1), 133–146. https://doi.org/10.1093/brain/112.1.133
Wexler, A. G., & Goodman, A. L. (2017). An insider’s perspective: Bacteroides as a window into the microbiome. Nature Microbiology, 2(5), 1–11.
Wright, E. K., Kamm, M. A., Teo, S. M., Inouye, M., Wagner, J., & Kirkwood, C. D. (2015). Recent advances in characterizing the gastrointestinal microbiome in Crohn’s disease: A systematic review. Inflammatory Bowel Diseases, 21(6), 1219–1228. https://doi.org/10.1097/mib.0000000000000382
Wunsch, M., Jabari, S., Voussen, B., Enders, M., Srinivasan, S., Cossais, F., et al. (2017). The enteric nervous system is a potential autoimmune target in multiple sclerosis. Acta Neuropathologica, 134, 281–295.
Xiong, T., & Turner, J. E. (2018). Innate lymphoid cells in autoimmunity and chronic inflammatory diseases. Semin Immunopathol, 40(4), 393–406. https://doi.org/10.1007/s00281-018-0670-4
Xiu, W., Chen, Q., Wang, Z., Wang, J., & Zhou, Z. (2020). Microbiota-derived short chain fatty acid promotion of Amphiregulin expression by dendritic cells is regulated by GPR43 and Blimp-1. Biochemical and Biophysical Research Communications, 533(3), 282–288.
Yamashita, M., Ukibe, K., Matsubara, Y., Hosoya, T., Sakai, F., Kon, S., et al. (2018). Lactobacillus helveticus SBT2171 attenuates experimental autoimmune encephalomyelitis in mice. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2017.02596
Yao, C., Muir, J., & Gibson, P. (2016). Insights into colonic protein fermentation, its modulation and potential health implications. Alimentary Pharmacology & Therapeutics, 43(2), 181–196.
Yokote, H., Miyake, S., Croxford, J. L., Oki, S., Mizusawa, H., & Yamamura, T. (2008). NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. The American Journal of Pathology, 173(6), 1714–1723. https://doi.org/10.2353/ajpath.2008.080622
Yu, L., Zhong, X., He, Y., & Shi, Y. (2020). Butyrate, but not propionate, reverses maternal diet-induced neurocognitive deficits in offspring. Pharmacological Research, 160, 105082.
Yurkovetskiy, L., Burrows, M., Khan, A. A., Graham, L., Volchkov, P., Becker, L., et al. (2013). Gender bias in autoimmunity is influenced by microbiota. Immunity, 39(2), 400–412.
Zapolska-Downar, D., Siennicka, A., Kaczmarczyk, M., Kołodziej, B., & Naruszewicz, M. (2004). Butyrate inhibits cytokine-induced VCAM-1 and ICAM-1 expression in cultured endothelial cells: The role of NF-kappaB and PPARalpha. Journal of Nutritional Biochemistry, 15(4), 220–228. https://doi.org/10.1016/j.jnutbio.2003.11.008
Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., et al. (2015). Personalized nutrition by prediction of glycemic responses. Cell, 163(5), 1079–1094. https://doi.org/10.1016/j.cell.2015.11.001
Zeng, B., Shi, S., Ashworth, G., Dong, C., Liu, J., & Xing, F. (2019). ILC3 function as a double-edged sword in inflammatory bowel diseases. Cell Death & Disease, 10(4), 315. https://doi.org/10.1038/s41419-019-1540-2
Zhao, L., Zhang, F., Ding, X., Wu, G., Lam, Y. Y., Wang, X., et al. (2018). Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science, 359(6380), 1151–1156. https://doi.org/10.1126/science.aao5774
Zhou, Z., Packialakshmi, B., Makkar, S., Dridi, S., & Rath, N. (2014). Effect of butyrate on immune response of a chicken macrophage cell line. Veterinary Immunology and Immunopathology, 162(1–2), 24–32.
Zozulya, A. L., & Wiendl, H. (2008). The role of regulatory T cells in multiple sclerosis. Nature Clinical Practice Neurology, 4(7), 384–398. https://doi.org/10.1038/ncpneuro0832
Acknowledgements
This work was funded by the Researchers Supporting Project Number (RSPD2024R603) King Saud University, Riyadh, Saudi Arabia
Author information
Authors and Affiliations
Contributions
A. B. C. D. E. F. G. H wrote the main manuscript text and A. B. C. editing text. A. B prepared figures. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Saadh, M.J., Ahmed, H.M., Alani, Z.K. et al. The Role of Gut-derived Short-Chain Fatty Acids in Multiple Sclerosis. Neuromol Med 26, 14 (2024). https://doi.org/10.1007/s12017-024-08783-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12017-024-08783-4